• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2020 o Market outlook: Forecast for 2020 - 2025 • Five Forces Analysis o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Application o Market segments o Comparison by Application o Oncology and endocrinology testing - Market size and forecast 2020-2025 o Infectious disease testing - Market size and forecast 2020-2025 o Autoimmune testing - Market size and forecast 2020-2025 o Allergy testing - Market size and forecast 2020-2025 o Market opportunity by Application • Market Segmentation by End-user o Market segments o Comparison by End-user o Hospitals and clinics - Market size and forecast 2020-2025 o Diagnostic laboratories - Market size and forecast 2020-2025 o Market opportunity by End-user • Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2020-2025 o Europe - Market size and forecast 2020-2025 o Asia - Market size and forecast 2020-2025 o ROW - Market size and forecast 2020-2025 o Key leading countries o Market opportunity By Geographical Landscape o Market drivers o Market challenges o Market trends • Vendor Landscape o Overview o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Abbott Laboratories o Bio Rad Laboratories Inc. o Danaher Corp. o DiaSorin SpA o F. Hoffmann-La Roche Ltd. o Merck KGaA o Siemens AG o Sofina SA o The Carlyle Group Inc. o Thermo Fisher Scientific Inc. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibits • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Key Finding 9 • 9: Parent market • 10: Market characteristics • 11: Offerings of vendors included in the market definition • 12: Market segments • 13: Global - Market size and forecast 2020 - 2025 ($ million) • 14: Global market: Year-over-year growth 2020 - 2025 (%) • 15: Five forces analysis 2020 & 2025 • 16: Bargaining power of buyers • 17: Bargaining power of suppliers • 18: Threat of new entrants • 19: Threat of substitutes • 20: Threat of rivalry • 21: Market condition - Five forces 2020 • 22: Application - Market share 2020-2025 (%) • 23: Comparison by Application • 24: Oncology and endocrinology testing - Market size and forecast 2020-2025 ($ million) • 25: Oncology and endocrinology testing - Year-over-year growth 2020-2025 (%) • 26: Infectious disease testing - Market size and forecast 2020-2025 ($ million) • 27: Infectious disease testing - Year-over-year growth 2020-2025 (%) • 28: Autoimmune testing - Market size and forecast 2020-2025 ($ million) • 29: Autoimmune testing - Year-over-year growth 2020-2025 (%) • 30: Allergy testing - Market size and forecast 2020-2025 ($ million) • 31: Allergy testing - Year-over-year growth 2020-2025 (%) • 32: Market opportunity by Application • 33: End-user - Market share 2020-2025 (%) • 34: Comparison by End-user • 35: Hospitals and clinics - Market size and forecast 2020-2025 ($ million) • 36: Hospitals and clinics - Year-over-year growth 2020-2025 (%) • 37: Diagnostic laboratories - Market size and forecast 2020-2025 ($ million) • 38: Diagnostic laboratories - Year-over-year growth 2020-2025 (%) • 39: Market opportunity by End-user • 40: Customer landscape • 41: Market share By Geographical Landscape 2020-2025 (%) • 42: Geographic comparison • 43: North America - Market size and forecast 2020-2025 ($ million) • 44: North America - Year-over-year growth 2020-2025 (%) • 45: Europe - Market size and forecast 2020-2025 ($ million) • 46: Europe - Year-over-year growth 2020-2025 (%) • 47: Asia - Market size and forecast 2020-2025 ($ million) • 48: Asia - Year-over-year growth 2020-2025 (%) • 49: ROW - Market size and forecast 2020-2025 ($ million) • 50: ROW - Year-over-year growth 2020-2025 (%) • 51: Key leading countries • 52: Market opportunity By Geographical Landscape ($ million) • 53: Impact of drivers and challenges • 54: Vendor landscape • 55: Landscape disruption • 56: Industry risks • 57: Vendors covered • 58: Market positioning of vendors • 59: Abbott Laboratories - Overview • 60: Abbott Laboratories - Business segments • 61: Abbott Laboratories - Key offerings • 62: Abbott Laboratories - Key customers • 63: Abbott Laboratories - Segment focus • 64: Bio Rad Laboratories Inc. - Overview • 65: Bio Rad Laboratories Inc. - Business segments • 66: Bio Rad Laboratories Inc. - Key offerings • 67: Bio Rad Laboratories Inc. - Key customers • 68: Bio Rad Laboratories Inc. - Segment focus • 69: Danaher Corp. - Overview • 70: Danaher Corp. - Business segments • 71: Danaher Corp. - Key offerings • 72: Danaher Corp. - Key customers • 73: Danaher Corp. - Segment focus • 74: DiaSorin SpA - Overview • 75: DiaSorin SpA - Business segments • 76: DiaSorin SpA - Key offerings • 77: DiaSorin SpA - Key customers • 78: DiaSorin SpA - Segment focus • 79: F. Hoffmann-La Roche Ltd. - Overview • 80: F. Hoffmann-La Roche Ltd. - Business segments • 81: F. Hoffmann-La Roche Ltd. - Key offerings • 82: F. Hoffmann-La Roche Ltd. - Key customers • 83: F. Hoffmann-La Roche Ltd. - Segment focus • 84: Merck KGaA - Overview • 85: Merck KGaA - Business segments • 86: Merck KGaA - Key offerings • 87: Merck KGaA - Key customers • 88: Merck KGaA - Segment focus • 89: Siemens AG - Overview • 90: Siemens AG - Business segments • 91: Siemens AG - Key offerings • 92: Siemens AG - Key customers • 93: Siemens AG - Segment focus • 94: Sofina SA - Overview • 95: Sofina SA - Product and service • 96: Sofina SA - Key offerings • 97: Sofina SA - Key customers • 98: Sofina SA - Segment focus • 99: The Carlyle Group Inc. - Overview • 100: The Carlyle Group Inc. - Business segments • 101: The Carlyle Group Inc. - Key offerings • 102: The Carlyle Group Inc. - Key customers • 103: The Carlyle Group Inc. - Segment focus • 104: Thermo Fisher Scientific Inc. - Overview • 105: Thermo Fisher Scientific Inc. - Business segments • 106: Thermo Fisher Scientific Inc. - Key offerings • 107: Thermo Fisher Scientific Inc. - Key customers • 108: Thermo Fisher Scientific Inc. - Segment focus • 109: Currency conversion rates for US$ • 110: Research Methodology • 111: Validation techniques employed for market sizing • 112: Information sources • 113: List of abbreviations

Abbott Laboratories, Bio Rad Laboratories Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann-La Roche Ltd., Merck KGaA, Siemens AG, Sofina SA, The Carlyle Group Inc., Thermo Fisher Scientific Inc.